| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 03/04/2004 | US20040043933 Mixture with pH moderator, antioxidant and Group 2a salt; anticoagulant |
| 03/04/2004 | US20040043932 Leptin-related peptides |
| 03/04/2004 | US20040043931 Stimulation, expansion of lymphocytes; polynucleotides; genetic engineering |
| 03/04/2004 | US20040043930 Novel proteins and nucleic acids encoding same |
| 03/04/2004 | US20040043929 Novel proteins and nucleic acids encoding same |
| 03/04/2004 | US20040043928 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 03/04/2004 | US20040043927 Wound healing agents; anticancer agents; cardiovascular disorders |
| 03/04/2004 | US20040043926 Comprises polypeptides for diagnosing, treating and preventing cardiomyopathy, atherosclerosis and cancer |
| 03/04/2004 | US20040043925 Cyclic depsipeptides; veterinary medicine |
| 03/04/2004 | US20040043924 Uses of keratinocyte growth factor-2 |
| 03/04/2004 | US20040043922 Treatment of case-ready food products with immobilized lactoferrin (Im-LF) and the products so produced |
| 03/04/2004 | US20040043921 Substances and their uses |
| 03/04/2004 | US20040043919 Method for the treatment of neurological and neuropsychological disorders |
| 03/04/2004 | US20040043486 Inserting exogenous nucleotide sequences into genome of target mammalian cells using transpoases |
| 03/04/2004 | US20040043472 Novel substances k97-0239 and process for producing the same |
| 03/04/2004 | US20040043470 Regulation of human histone deacetylase |
| 03/04/2004 | US20040043457 Bifunctional fusion proteins with glucocerebrosidase activity |
| 03/04/2004 | US20040043454 Growth arrest homeobox gene |
| 03/04/2004 | US20040043450 Bioactive peptide for cell adhesion |
| 03/04/2004 | US20040043448 Nucleotide sequences |
| 03/04/2004 | US20040043438 Allergen mutants |
| 03/04/2004 | US20040043435 Method for the detection of apoptosis by determining apoptosis-specific markers released into an extracellular medium through cellular release mechanisms |
| 03/04/2004 | US20040043425 Screening, detecting and/or prognosing respiratory system disorders; bronchodilator agents |
| 03/04/2004 | US20040043419 Immobilized chaperone protein cabable of illicting immunological response for use in diagnose, prevention and treatment of infections, and tumors |
| 03/04/2004 | US20040043413 Comprises nucleotide sequences coding cytochrome p450 for diagnosis, prevention and treatment of cancer, parkinson's and developmental disorder |
| 03/04/2004 | US20040043412 Extracellular novel RAGE binding protein (EN-RAGE) and uses thereof |
| 03/04/2004 | US20040043411 DSP-11 dual-specificity phosphatase |
| 03/04/2004 | US20040043402 Interferon-alpha induced gene |
| 03/04/2004 | US20040043393 AXOR35, a G-protein coupled receptor |
| 03/04/2004 | US20040043391 Leptospira vaccine antigens for the prevention of Leptospirosis |
| 03/04/2004 | US20040043382 Novel proteins and nucleic acids encoding same |
| 03/04/2004 | US20040043375 Regulation of human serine-threonine protein kinase |
| 03/04/2004 | US20040043084 Incubation extractin presence of aerobic metabolizing microorganisms; cosmetics, drugs |
| 03/04/2004 | US20040043076 Containing protein active material; solvent-free |
| 03/04/2004 | US20040043063 In situ transfection; gene therapy; protein in liposome capsules |
| 03/04/2004 | US20040043055 Method of reducing body weight and/or body fat with L-glutamine compounds |
| 03/04/2004 | US20040043036 Binding to protein; adjustment concentration of calcium compound in cells |
| 03/04/2004 | US20040043031 Methods for promoting growth of bone, ligament, and cartilage |
| 03/04/2004 | US20040043029 Novel antibodies reactive with human carcinomas |
| 03/04/2004 | US20040043027 Antiproliferative agents |
| 03/04/2004 | US20040043026 Treatment and prevention of abnormal scar formation in keloids and other cutaneous or internal wounds or lesions |
| 03/04/2004 | US20040043025 Growth differentiation factor-12 |
| 03/04/2004 | US20040043024 Genetic engineering; isolation nucleic acids binded to heparin |
| 03/04/2004 | US20040043022 Immunology diseases; rheumatic disorders; anticancer agents; antiinflammatory agents; multiple sclerosis; lymphocyte stimulants |
| 03/04/2004 | US20040043021 Asthma therapy, diagnosis |
| 03/04/2004 | US20040043018 Adjust concentration of interleukins |
| 03/04/2004 | US20040043017 Prothrombin activating protein |
| 03/04/2004 | US20040043016 Fibrinogen plus a non-plasmin-acting fibrinolysis inhibitor for the reduction or prevention of adhesion formation |
| 03/04/2004 | US20040043015 Platelet aggregation inhibitor and supplement food effective for inhibiting platelet aggregation |
| 03/04/2004 | US20040043014 Bacillus culture product; anticoagulants; mixture of nattokinase and vitamin k |
| 03/04/2004 | US20040043010 Delivery of bioactive compounds to an organism |
| 03/04/2004 | US20040043003 Clinical grade vectors based on natural microflora for use in delivering therapeutic compositions |
| 03/04/2004 | US20040043002 Polyol-IFN-beta conjugate and composition containing same |
| 03/04/2004 | US20040043000 Method of modulating fertility in animals |
| 03/04/2004 | US20040042999 Cyclic administering saturation dosage underneath skin |
| 03/04/2004 | US20040042997 Administering granulocyte colony stimulating factor |
| 03/04/2004 | US20040042996 Aging resistance |
| 03/04/2004 | US20040042968 Prevent injuries from infections, injuries, ulcers; mixture of hepacyte growth factor and antibiotic |
| 03/04/2004 | DE10261126A1 Lagerungsstabile, flüssige Fibrinogen-Formulierung Storage stable liquid fibrinogen formulation |
| 03/04/2004 | DE10239477A1 Treating acute or chronic skin diseases, especially psoriasis, eczema or acne, using thiol-containing proteolytic enzymes such as bromelain |
| 03/04/2004 | DE10237146A1 Verwendung von Treosulfan und Derivaten davon zur Behandlung der Multiplen Sklerose Use of treosulphan and derivatives thereof for the treatment of multiple sclerosis |
| 03/04/2004 | DE10233082A1 Fluoreszierendes Protein Fluorescent protein |
| 03/04/2004 | CA2535952A1 Use of granzyme b as an hsp70/hsp70 peptide dependent inducer of apoptosis in tumor cells |
| 03/04/2004 | CA2504019A1 Stromal cell-derived factor-1 mediates stem cell homing and tissue regeneration in ischemic cardiomyopathy |
| 03/04/2004 | CA2496831A1 Treating alzheimers using delipidated protein particles |
| 03/04/2004 | CA2496732A1 Synthetic heparin-binding growth factor analogs |
| 03/04/2004 | CA2496686A1 A pharmaceutical preparation containing palladium complex compounds and the uses thereof for treating cancer and autoimmune disease |
| 03/04/2004 | CA2496572A1 Compositions and methods of therapy for cancers characterized by expression of the tumor-associated antigen mn/ca ix |
| 03/04/2004 | CA2496485A1 Use of an anti-g-csf or anti-g -csfr antibody or a soluble g- csfr for the treatment or prophylaxis of arthritis |
| 03/04/2004 | CA2496384A1 Lectin compositions and methods for modulating an immune response to an antigen |
| 03/04/2004 | CA2496242A1 T-cell epitopes in staphylococcal enterotoxin b |
| 03/04/2004 | CA2496236A1 Preventives/remedies for cancer |
| 03/04/2004 | CA2496234A1 Salt-inducible kinases 2 and use thereof |
| 03/04/2004 | CA2496215A1 Template-fixed peptidomimetics with antibacterial activity |
| 03/04/2004 | CA2495972A1 Heterocarpin, a plant-derived protein with anti-cancer properties |
| 03/04/2004 | CA2495794A1 A genomic approach to identification of novel broad-spectrum antimicrobial peptides from bony fish |
| 03/04/2004 | CA2495354A1 An agent for inhibiting articular cartilage extracellular matrix degradation |
| 03/04/2004 | CA2494974A1 Il-7 drug substance, composition, preparation and uses |
| 03/04/2004 | CA2494963A1 T-cell epitopes in erythropoietin |
| 03/04/2004 | CA2494806A1 Expression vectors encoding epitopes of target-associated antigens |
| 03/04/2004 | CA2494766A1 Rnai probes targeting cancer-related proteins |
| 03/04/2004 | CA2494764A1 Treatment of melanoma by reduction in clusterin levels |
| 03/04/2004 | CA2493471A1 Compounds binding to p-selectin |
| 03/04/2004 | CA2490721A1 Enzyme containing composition, process of producing said composition and its use |
| 03/03/2004 | EP1394551A2 Integrin as a predictor of endometriosis |
| 03/03/2004 | EP1394274A2 Methods of testing for bronchial asthma or chronic obstructive pulmonary disease |
| 03/03/2004 | EP1394261A2 Method for producing catalytic antibodies (variants), antigens for immunisation and nucleotide sequence |
| 03/03/2004 | EP1394256A2 HCV genomic sequences for diagnostics and therapeutics |
| 03/03/2004 | EP1394254A1 Method of producing antigens, antigens and their use |
| 03/03/2004 | EP1394184A1 Apoptose inhibitor |
| 03/03/2004 | EP1394180A1 Synthetic mimetic molecules of physiological binding molecules |
| 03/03/2004 | EP1394179A1 Process for producing erythropoietin free from animal proteins |
| 03/03/2004 | EP1394178A1 Peptide fragments of myelin basic protein, their pharmaceutical compositions and their use in treating multiple sclerosis |
| 03/03/2004 | EP1394177A1 High density lipoprotein-reactive peptides |
| 03/03/2004 | EP1394175A1 Inhibitors of interleukin-1beta converting enzyme |
| 03/03/2004 | EP1393776A1 Use of genes identified to be involved in tumor development for the development of anti-cancer drugs and diagnosis of cancer |
| 03/03/2004 | EP1393743A1 Agents modulating UPA/UPAR activity for the treatment of AIDS |
| 03/03/2004 | EP1393742A1 Use of protein kinase N beta |
| 03/03/2004 | EP1393741A1 Storage-stable, liquid fibrinogen-formulation |
| 03/03/2004 | EP1393740A1 Novel remedies for neurodegenerative disease |